Zacks Investment Research on MSN
Quanterix submits FDA 510(k) for multi-analyte Alzheimer's blood test
Quanterix QTRX recently announced the submission of a 510(k) premarket notification to the FDA for its multi-analyte ...
Engineered yeast cells can mimic real cancer cells and be used to test new cancer immunotherapies much faster, benefiting patients.
The NHS wants to roll out blood, urine and saliva tests that could pick up signals of more than 50 cancers before symptoms ...
Telehealth company Hims & Hers has added Grail’s blood cancer test Galleri to its offerings as the medtech continues to gather up trial data for a potential FDA approval next year. | Telehealth ...
Today, Hims & Hers Health, Inc. (NYSE: HIMS), the leading digital health and wellness platform, launched access to the Hims & ...
Early detection tests that pick up multiple cancers – such as breath and saliva tests – could become part of NHS screening within a decade, the Government has said.
On World Cancer Day, we look at the companies accelerating breakthroughs across the cancer pipeline, from screening to recovery.
During the Jan. 28 Alzheimer's Drug Discover Foundation lecture, panelists said the tests will revolutionize diagnosis and ...
A research team led by La Trobe University has developed a single-use test strip that could ultimately change how diseases ...
The test integrates the measurements of five proteins to assess if patients have the brain pathology characteristic of Alzheimer's disease.
A multidisciplinary team of University of Cincinnati Cancer Center researchers has received a $40,000 Ride Cincinnati grant to study the use of a delayed release preparation or wafer of an ...
Swedish researchers discovered a blood test that can detect Parkinson's disease up to 20 years before symptoms appear, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results